Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valette Extended vs Conventional Regimen for Contraception
NCT00302666Phase 3Completed
- Sponsor
- Bayer
- Start
- Jun 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dienogest + ethinyl estradiol in contraception (2 arms), sponsored by Bayer. Primary endpoint: Bleeding Pattern. Started Jun 2003; status: completed.
02
Drugs
dienogest + ethinyl estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT00302666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00302666.